Rigel Pharmaceuticals (RIGL) EPS (Basic) (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.84% |
| Dec 31, 2025 | 860.00% |
| Sep 30, 2025 | -53.45% |
| Jun 30, 2025 | 420.31% |
| Mar 31, 2025 | -20.99% |
| Dec 31, 2024 | 14.08% |
| Sep 30, 2024 | 1,283.33% |
| Jun 30, 2024 | 87.23% |
| Mar 31, 2024 | -1,040.00% |
| Dec 31, 2023 | 115.15% |
| Sep 30, 2023 | 13.16% |
| Jun 30, 2023 | -375.00% |
| Mar 31, 2023 | 97.41% |
| Dec 31, 2022 | -2,709.09% |
| Sep 30, 2022 | -37.50% |
| Jun 30, 2022 | 50.00% |
| Mar 31, 2022 | -14.29% |
| Dec 31, 2021 | -16.67% |
| Sep 30, 2021 | -50.00% |
| Jun 30, 2021 | -134.78% |
| Mar 31, 2021 | 309.09% |
| Dec 31, 2020 | -37.50% |
| Sep 30, 2020 | 20.00% |
| Jun 30, 2020 | -176.92% |
| Mar 31, 2020 | 230.00% |
| Dec 31, 2019 | -42.86% |
| Sep 30, 2019 | 41.67% |
| Jun 30, 2019 | -9.09% |
| Mar 31, 2019 | -650.00% |
| Dec 31, 2018 | 114.29% |
| Sep 30, 2018 | 12.50% |
| Jun 30, 2018 | 5.88% |
| Mar 31, 2018 | 5.56% |
| Dec 31, 2017 | -28.57% |
| Sep 30, 2017 | 12.50% |
| Jun 30, 2017 | -23.08% |
| Mar 31, 2017 | 18.75% |
| Dec 31, 2016 | 33.33% |
| Sep 30, 2016 | -60.00% |
| Jun 30, 2016 | 21.05% |
| Mar 31, 2016 | -35.71% |
| Dec 31, 2015 | -75.00% |
| Sep 30, 2015 | 50.00% |
| Jun 30, 2015 | 23.81% |
| Mar 31, 2015 | 16.00% |
| Dec 31, 2014 | -4.17% |
| Sep 30, 2014 | 17.24% |
| Jun 30, 2014 | -16.00% |
| Mar 31, 2014 | -31.58% |
| Dec 31, 2013 | 29.63% |
| Sep 30, 2013 | -3.85% |
| Jun 30, 2013 | 10.34% |
| Mar 31, 2013 | 3.33% |
| Dec 31, 2012 | 16.67% |
| Sep 30, 2012 | -2.86% |
| Jun 30, 2012 | -9.38% |
| Mar 31, 2012 | 13.51% |
| Dec 31, 2011 | -48.00% |
| Sep 30, 2011 | 32.43% |
| Jun 30, 2011 | 7.50% |
| Mar 31, 2011 | -21.21% |
| Dec 31, 2010 | -134.02% |
| Sep 30, 2010 | 86.54% |